# Aptose Biosciences Inc. sinks 10% after presenting highlights from clinical update webcast featuring latest available data on AML drug Tuspetinib
**FDA Update**

**2023-10-30 14:00**

**https://www.ainvest.com/news/aptose-biosciences-inc-sinks-10-after-presenting-highlights-from-clinical-update-webcast-featuring-latest-available-data-on-aml-drug-tuspetinib-2310100036ea994e4e5dc9d6/**

Aptose Biosciences Inc. sinks 10% after presenting highlights from clinical update webcast featuring latest available data on AML drug Tuspetinib